Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis—increased serum ferritin or transfusion load does not
Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo
FAK silencing inhibits leukemogenesis in BCR/ABL-transformed hematopoietic cells
genetic polymorphisms in glutathione S-transferases and cytochrome P450s, tobacco smoking, and risk of non-Hodgkin lymphoma
Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation
First-line therapy for chronic myeloid leukemia: past, present, and future
The value of looking at smear cells
Juvenile myelomonocytic leukemia with t(7;11)(p15;p15) and NUP98-HOXA11 fusion
Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation
Persistent neutropenia in chronic myelogenous leukemia in chronic phase treated with imatinib mesylate
BCR-ABL positive chronic myeloid leukemia with concurrent JAK2V617F positive myelodysplastic syndrome/myeloproliferative neoplasm (RARS-T)
Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogenetics
Lung function tests in sickle cell patients
Lung function tests in patients with sickle cell disease
Pulmonary hypertension does not affect the autonomic nervous system dysfunction of sickle cell disease
Usefulness and limitations of Bayesian network model as a mortality risk assessment tool in sickle cell anemia
Cyclosporine therapy in refractory/relapsed patients with thrombotic thrombocytopenic purpura
Clinical efficacy of WT1 peptide vaccination in patients with acute myelogenous leukemia and myelodysplastic syndrome
Effective treatment for de novo hepatitis B with nucleotide analogue in patients with hematological malignancies
Postsplenectomy vascular complications
The influence of treatment in specialized centers on survival of patients with thalassemia major